Acetyl chloride → HCID 67538191, compound
Reaction equation
[NH2:1][C:2]1[N:6]([CH3:7])[C:5](=[O:8])[C:4]([C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([NH2:25])[CH:20]=2)([C:9]2[CH:14]=[CH:13][C:12]([O:15][CH:16]([F:18])[F:17])=[CH:11][CH:10]=2)[N:3]=1.[C:26]([Cl:29])(=[O:28])[CH3:27].CCN(CC)CC>C1COCC1>[ClH:29].[NH2:1][C:2]1[N:6]([CH3:7])[C:5](=[O:8])[C:4]([C:19]2[CH:20]=[C:21]([NH:25][C:26](=[O:28])[CH3:27])[CH:22]=[CH:23][CH:24]=2)([C:9]2[CH:14]=[CH:13][C:12]([O:15][CH:16]([F:17])[F:18])=[CH:11][CH:10]=2)[N:3]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 2-amino-5-(3-amino-phenyl)-5-(4-difluoromethoxy-phenyl)-3-methyl-3,5-dihydro-imidazol-4-one (88 mg, 0.25 mmol), acetyl chloride (20 mg, 0.25 mmol), NEt3 (51 mg, 0.51 mmol) in THF (2.5 mL) was stirred at rt for 1 h, concentrated and purified by reverse-phase HPLC followed by treatment with hydrochloric acid to provide the title compound (42 mg, 43%), characterized by NMR and mass spectral analyses. MS (ES+) m/e 389 (M+H)+.
Workup
- concentrationconcentrated
- custompurified by reverse-phase HPLC
Sources & evidence
- ORD record
- ord-1c3d5e0fc39a4c7c893832d664ff2892
- Source dataset
- uspto-grants-2010_05
- Patent number
- US07723368B2
Reaction notes
Loading…